Metabolomics of World Trade Center-Lung Injury: Biomarker Validation, Longitudinal Assessment and Dietary Intervention

Project Number
1 U01 OH011300-01A1
NYU School of Medicine
Fiscal Year Awarded
Project Duration
4 years


The adverse impact on quality of life and sizable cost of WTC-lung injury (WTC-LI) are public health concerns. We propose to Identify and Validate metabolic contributors of WTC-LI through comprehensive metabolomics profiling and integration of relevant clinical, environmental, and serum biomarkers. We propose to investigate targeted behavioral dietary modification to alter modifiable risk factors and metabolomic (scientific study of chemical processes involving metabolites) biomarkers that may mitigate disease severity and improve the health and well-being of WTC exposed patients.


Image of Anna  Nolan, MD          MS
Principal Investigator: Anna Nolan, MD MS
NYU School of Medicine
(212) 263-7283